Ophthalmic Sciences

Ophthalmic Sciences aims to cross the last frontier of ophthalmic care: remote diagnosis and monitoring. Founded in 2019, the company is led by veterans in healthcare and business as well as experts in image processing. Ophthalmic Sciences' patented technology initially targets the $7 billion glaucoma market and can be applied to many medical applications, such as early detection of cataracts and corneal edema, early identification of central/branch retinal vein occlusion, and eye movement disorders. The company is part of eHealth Ventures, an accelerator that provides world-class clinical, operational, and commercial networks.